Femasys Inc. Common Stock
$2.53
-$0.03 (-1.17%)
$2.52Day Range$2.74
Key Statistics
Market Cap
$21.44M
Shares Outstanding
8.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 18, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$2.61
Day High
$2.74
Day Low
$2.52
Volume
35.6K
VWAP
$2.57
Prev Close
$2.56
Transactions
--
Acc. Volume
--
About Femasys Inc. Common Stock
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 384154 employees3950 JOHNS CREEK COURT, SUWANEE, GA, 30024770-500-3910IPO Jun 18, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001339005
- Composite FIGI
- BBG004M23R63
- Share Class FIGI
- BBG004M23R72
- Ticker Root
- FEMY
- SIC Code
- 3841
About Femasys Inc. Common Stock (FEMY) Stock
Femasys Inc. Common Stock (FEMY) closed the 2026-09-16 session at $2.53, down 1.17% versus the previous close (-0.03). The stock opened at $2.61 and traded between $2.52 and $2.74 during that session. Session trading volume was 36K shares. The volume-weighted average price (VWAP) is $2.57.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
Femasys Inc. Common Stock has a market capitalization of $21.4 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. FEMY is listed on the XNAS exchange. The company employs approximately 54 people. Femasys Inc. Common Stock is headquartered in SUWANEE, GA. The recorded listing date is 2021-06-18.
On this page you can find market FEMY stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.